Inventor · disambiguated record
Jeffrey S. Albert
Also filed as: ALBERT JEFFREY · ALBERT JEFFREY S · ALBERT JEFFREY SCOTT
13 granted patents·22 pending applications·15 citations·filing 2001–2024
86Inventor score
Top patents by PatentIndex Score
35 records- 0190US11365186B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2020·Granted Jun 21, 2022·3 cites·10 claims
- 0287US11981657B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 0385US10703740B2Substituted benzimidazoles, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Jul 7, 2020·3 cites·13 claims
- 0477US2024425481A1Substituted benzimidazoles, their preparation and their use as pharmaceuticalsEPIGENETIX INC·Filed 2024·Application pending·0 cites
- 0575US11597726B2Ring deuterated gaboxadol and its use for the treatment of psychiatric disordersCERTEGO THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·54 claims
- 0673US8071621B2Alkylsulphonamide quinolinesSIMPSON THOMAS·Filed 2009·Granted Dec 6, 2011·4 cites·4 claims
- 0769US10501459B2Substituted imidazo[1,2-a]pyridines as bromodomain inhibitorsNEOMED INST·Filed 2016·Granted Dec 10, 2019·1 cites·27 claims
- 0869US7964733B2Alkyl sulfoxide quinolines as NK-3 receptor ligandsASTRAZENECA AB·Filed 2006·Granted Jun 21, 2011·1 cites·8 claims
- 0968US7608628B2Alkylsulphonamide quinolinesASTRAZENECA AB·Filed 2006·Granted Oct 27, 2009·1 cites·2 claims
- 1055US2023183238A1Ring deuterated gaboxadol and its use for the treatment of psychiatric disordersCERTEGO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1151US7235541B2Neurokinin antagonists for use as medicamentsASTRAZENECA AB·Filed 2005·Granted Jun 26, 2007·0 cites·16 claims
- 1251US2020299262A1Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2019·Application pending·0 cites
- 1351US2020299291A1Substituted imidazopyridines, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2019·Application pending·0 cites
- 1446US6846814B2Neurokinin antagonists for use as medicamentsASTRAZENECA AB·Filed 2001·Granted Jan 25, 2005·0 cites·15 claims
- 1545US2009030033A1Novel Compounds 894ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1644US10501438B2Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Dec 10, 2019·0 cites·25 claims
- 1744US2009176850A1Novel 2-Amino-Imidazole-4-One Compounds And Their Use In The Manufacture Of A Medicament To Be Used In The Treatment Of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration And DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1844US2008318985A1Novel 2-Aminopyrimidinone Or 2-Aminopyridinone Derivatives and Their UseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1943US2008255167A1Novel 2-Aminopyrimidine or 2-Aminiopyridinone Derivatives and Their UseALBERT JEFFREY·Filed 2006·Application pending·0 cites
- 2043US2008293709A1Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related PathologiesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2142US2009221579A1Substituted Amino-Compounds and Uses ThereofALBERT JEFFREY SCOTT·Filed 2005·Application pending·0 cites
- 2242US2009054445A1Amide Substituted QuinolinesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2342US2008287399A1Substituted Aminopyridines and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2442US2008234269A1N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor LigandsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2541US2008306110A1Alkylnitrile Quinolines as Nk-3 Receptor LigandsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2641US2009062282A1Substituted Amino-Pyrimidones and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2741US2008200504A1Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2841US2008287492A1Alkylpyridyl Quinolines as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2941US2008280949A1Oxopyridyl Quinoline Amides as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3041US2016039842A1Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitorsEPIGENETIX INC·Filed 2014·Application pending·0 cites
- 3141US2008194622A1Quinoline 3-Sulfonate Esters as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3238US2009215801A9Novel 2-Aminopyrimidinone Derivatives And Their UseASTRAZENECA AB SODERTAIJE SWED·Filed 2006·Application pending·0 cites
- 3336US10836742B2N-substituted bicyclic lactams, their preparation and their use as pharmaceuticalsNEOMED INST·Filed 2016·Granted Nov 17, 2020·0 cites·25 claims
- 3436US10472352B2Rac inhibitorsGeneyus LLC·Filed 2018·Granted Nov 12, 2019·0 cites·18 claims
- 3531US2012094995A12-aza-bicyclo[2.2.1]heptane compounds and uses thereofALBERT JEFFREY SCOTT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →